Crinetics Pharmaceuticals, Inc. (CRNX)
55.99
-0.44
(-0.78%)
USD |
NASDAQ |
Jan 16, 16:00
57.00
+1.01
(+1.80%)
After-Hours: 20:00
Crinetics Pharmaceuticals SG&A Expense (TTM): 165.81M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 715.08M |
| GT Biopharma, Inc. | 6.564M |
| Axsome Therapeutics, Inc. | 514.57M |
| Sutro Biopharma, Inc. | 41.39M |
| Gossamer Bio, Inc. | 36.12M |